Fig. 1From: Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseasesComparison of survival curves for the primary outcomes between patients on VKAs or DOACs at COVID-19 diagnosis after propensity score matching. Purple line: Prior VKA use; Green line: Prior DOAC useBack to article page